9th Circ. Ruling May Help Pharma Cos. Avert Investor Claims

On Aug. 20, the U.S. Court of Appeals for the Ninth Circuit affirmed the dismissal of Sneed v. Talphera Inc., a securities fraud class action. The plaintiffs alleged that a pharmaceutical...

Already a subscriber? Click here to view full article